[{"address1": "18702 N. Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises of AL102, a gamma secretase inhibitor which is in phase 3 clinical trial for the treatment of desmoid tumors; IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates which is in phase 1 clinical trial; and preclinical asset consist of IM-3050, a fibroblast activation protein targeted radioligand therapy. It also develops solid tumor ADC drug candidates which includes IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 118, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1433088, "exercisedValue": 0, "unexercisedValue": 12996163}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 50, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.2, "open": 6.14, "dayLow": 6.09, "dayHigh": 7.13, "regularMarketPreviousClose": 6.2, "regularMarketOpen": 6.14, "regularMarketDayLow": 6.09, "regularMarketDayHigh": 7.13, "payoutRatio": 0.0, "beta": 2.059, "forwardPE": -2.4482758, "volume": 1300134, "regularMarketVolume": 1300134, "averageVolume": 1141368, "averageVolume10days": 1763530, "averageDailyVolume10Day": 1763530, "bid": 7.06, "ask": 7.15, "bidSize": 1, "askSize": 3, "marketCap": 617350016, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 21.72, "priceToSalesTrailing12Months": 68.28338, "fiftyDayAverage": 8.76, "twoHundredDayAverage": 11.752975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 303146400, "profitMargins": 0.0, "floatShares": 69554437, "sharesOutstanding": 86950704, "sharesShort": 9523078, "sharesShortPriorMonth": 9350699, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1095, "heldPercentInsiders": 0.16225, "heldPercentInstitutions": 0.57651, "shortRatio": 13.83, "shortPercentOfFloat": 0.113800004, "impliedSharesOutstanding": 86950704, "bookValue": 2.81, "priceToBook": 2.5266905, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -292963008, "trailingEps": -5.0, "forwardEps": -2.9, "enterpriseToRevenue": 33.53, "enterpriseToEbitda": -1.996, "52WeekChange": -0.62334216, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 7.1, "targetHighPrice": 38.0, "targetLowPrice": 20.0, "targetMeanPrice": 26.0, "targetMedianPrice": 24.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 217303008, "totalCashPerShare": 2.499, "ebitda": -151888992, "totalDebt": 4832000, "quickRatio": 4.001, "currentRatio": 4.076, "totalRevenue": 9041000, "debtToEquity": 2.667, "revenuePerShare": 0.154, "returnOnAssets": -0.49339, "returnOnEquity": -1.94629, "grossProfits": -120501000, "freeCashflow": -96318000, "operatingCashflow": -110794000, "revenueGrowth": -0.284, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -20.306059, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 7.18, "postMarketChange": 0.0799999, "regularMarketChange": 0.9000001, "regularMarketDayRange": "6.09 - 7.13", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1141368, "fiftyTwoWeekLowChange": 1.9499998, "fiftyTwoWeekLowChangePercent": 0.37864074, "fiftyTwoWeekRange": "5.15 - 21.72", "fiftyTwoWeekHighChange": -14.619999, "fiftyTwoWeekHighChangePercent": -0.67311233, "fiftyTwoWeekChangePercent": -62.334217, "earningsTimestamp": 1742414700, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.0, "epsForward": -2.9, "epsCurrentYear": -2.296, "priceEpsCurrentYear": -3.0923345, "fiftyDayAverageChange": -1.6600003, "fiftyDayAverageChangePercent": -0.18949775, "marketState": "CLOSED", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "postMarketChangePercent": 1.12676, "twoHundredDayAverageChange": -4.6529756, "twoHundredDayAverageChangePercent": -0.39589766, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744410659, "regularMarketTime": 1744401601, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 14.516131, "regularMarketPrice": 7.1, "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]